Product information

From Health Canada

Current status:

Cancelled Pre Market

Current status date:

2018-07-24

Original market date: See footnote 1

Product name:

NOVO-ETODOLAC 200 MG

DIN:

02242205 Electronic product monograph is not available

Company:

NOVOPHARM LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

28:08.04.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

M01AB08 ETODOLAC

Active ingredient group (AIG) number:See footnote5

0116345001

List of active ingredient(s)
Active ingredient(s) Strength
ETODOLAC 200 MG / CAP
Version 4.0.2
Date modified: